Annual report [Section 13 and 15(d), not S-K Item 405]

Description of Business and Summary of Significant Accounting Policies - Investments (Details)

v3.25.2
Description of Business and Summary of Significant Accounting Policies - Investments (Details)
$ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
Sep. 01, 2022
USD ($)
Dec. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Payments in Investment         $ 15,000      
Gain (loss) on equity method investment         938 $ (6,841) $ (1,143)  
Revenues, net         $ 1,219,635 $ 1,159,060 1,136,702  
Proceeds from divestiture             17,824  
Gain on sale of Eminence       $ 11,700     11,682  
Eminence                
Goodwill, Impairment Loss               $ 8,300
Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration]               Selling, General and Administrative Expense
Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill)               $ 8,600
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]               Selling, General and Administrative Expense
Proceeds from divestiture   $ 17,800            
Protein Sciences | Eminence                
Revenues, net       $ 2,000        
Wilson Wolf Corporation                
Payments in Investment $ 232,000   $ 25,000          
Investment percentage 19.90%              
Forward Contract, Milestone, Multiple for Total Expected Payments         4.4      
Wilson Wolf Corporation | First Part of Forward Contract                
Forward Contract, Milestone, Annual Revenue Required $ 92,000              
Forward Contract, Milestone, Annual EBITDA $ 55,000              
Wilson Wolf Corporation | Second Part of Forward Contract                
Forward Contract, Milestone, Annual Revenue Required         $ 226,000      
Forward Contract, Milestone, Annual EBITDA         136,000      
Forward Contract, Additional Investment         $ 1,000,000      
Eminence                
Asset Impairment Charges             900  
Inventory write-down             $ 900